2026-01-06 - Analysis Report
Okay, let's break down this analysis of Procter & Gamble (PG).

**1. Return Rate Comparison vs. S&P 500 (VOO)**

*   **PG Overview:** Procter & Gamble is a multinational consumer goods corporation providing a wide range of branded products.
*   **PG Cumulative Return:** 18.59%
*   **VOO Cumulative Return:** 91.00%
*   **Divergence:** -72.4 (Relative Divergence: 3.1)

**Analysis:**

*   PG significantly underperformed the S&P 500 over the specified period.  The -72.4% divergence is substantial.
*   A relative divergence of 3.1 suggests the current divergence is near the *bottom* of its historical range.
*   **Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2016-2018  | 4.0%   | 10.7% | 1.0%   | 0.5  | 213.0  |
| 2017-2019  | 23.0%  | 10.7% | 5.0%   | 0.5  | 289.4  |
| 2018-2020  | 26.0%  | 17.9% | 5.0%   | 0.7  | 322.4  |
| 2019-2021  | 39.0%  | 17.9% | -5.0%  | 0.7  | 379.0  |
| 2020-2022  | 11.0%  | 17.9% | 13.0%  | 0.6  | 351.2  |
| 2021-2023  | 24.0%  | 15.9% | 23.0%  | 0.4  | 339.5  |
| 2022-2024  | 7.0%   | 15.9% | -12.0% | 0.4  | 388.4  |
| 2023-2025  | -19.0% | 21.6% | -81.0% | 0.2  | 332.1  |

*   **CAGR (Compound Annual Growth Rate):**  Fluctuates significantly.  The most recent period (2023-2025) shows a negative CAGR of -19.0%.
*   **MDD (Maximum Drawdown):**  Shows the largest peak-to-trough decline during the period, indicating risk.  The recent increase to 21.6% suggests increasing volatility.
*   **Alpha:** Represents the excess return compared to the benchmark.  The most recent period shows a very negative alpha (-81.0%), indicating substantial underperformance.
*   **Beta:** Measures volatility relative to the market. A Beta of less than 1 suggests PG is less volatile than the market, but the most recent Beta of 0.2 suggests that the relationship with the market is very weak.
*   **Cap(B):**  Market capitalization in billions.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 140.37
*   **Previous Close:** 141.79
*   **Change:** -1.0
*   **5-day SMA:** 143.69
*   **20-day SMA:** 143.36
*   **60-day SMA:** 146.97

**Analysis:**

*   The stock price closed down slightly today.
*   The 5-day and 20-day SMAs are below the 60-day SMA, indicating a short-term downward trend.  The 5-day is slightly *above* the 20-day, potentially suggesting a very mild short-term bounce.

**3. Indicators Analysis**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 53.00
*   **PPO (Percentage Price Oscillator):** 0.03
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (6 shares - Safe - MRI:0.80) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent Divergence Change:** 0.3 (+) (단기상승 - short-term rise)
*   **Expected Return (%):** 19.2

**Analysis:**

*   An MRI of 0.8 suggests a medium-risk investment environment.
*   An RSI of 53.00 is neutral, indicating neither overbought nor oversold conditions.
*   A PPO of 0.03 is near zero, meaning short and long term average prices are moving very closely to each other.
*   The hybrid signal recommends a buy, investing 90% of available cash into 6 shares, indicating potential upside, with some safety considerations.
*   The recent positive divergence change suggests a potential short-term upward trend.
*   The expected return of 19.2% is a key positive, implying a potential rebound.

**4. Recent News & Significant Events**

*   **Negative Sentiment:** Several headlines point to struggles in 2025 and an analyst downgrade.
*   **Mixed Signals:** Jim Cramer's comment ("Patience Is Going to Pay off") offers a counterpoint.
*   **Earnings Focus:**  Attention is directed towards the upcoming earnings report on January 22nd.
*   **Institutional Ownership:** High institutional ownership (69%) can lead to more stable trading but also coordinated selling pressure.

**Analysis:**

The news is a mixed bag.  While some articles highlight recent difficulties and downgrades, others suggest potential future recovery. The upcoming earnings report will be crucial.  High institutional ownership could amplify market reactions.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (~1.92 on a 1-5 scale)
*   **Target Price:** Average = 168.95, High = 186.00, Low = 148.00
* Recent Rating Changes: None

**Analysis:**

Despite the recent downgrades in news, the analyst consensus remains a "Buy". The average target price suggests significant upside potential from the current price of around 140. The lack of recent rating changes indicates that the opinion has not changed

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-24 | 2    | 22.39 B$ |
| 2025-04-24 | 1.58 | 19.78 B$ |
| 2025-01-22 | 1.94 | 21.88 B$ |
| 2024-10-18 | 1.65 | 21.74 B$ |
| 2025-10-24 | 1.65 | 21.74 B$ |

**Analysis:**
*The final data point is duplicated, probably unintentional.
*The last quarter (2025-10-24) showed the highest EPS and revenue in the examined period.
*There is seasonality in the data, the quarters ending in September (2024-10-18 and 2025-10-24) have had similar results.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|----------------|
| 2025-09-30 | $22.39B   | 51.37%          |
| 2025-06-30 | $20.89B   | 49.11%          |
| 2025-03-31 | $19.78B   | 50.98%          |
| 2024-12-31 | $21.88B   | 52.39%          |
| 2024-09-30 | $21.74B   | 52.06%          |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-09-30 | $53.27B   | 8.92%    |
| 2025-06-30 | $52.01B   | 6.95%    |
| 2025-03-31 | $52.27B   | 7.21%    |
| 2024-12-31 | $51.17B   | 9.05%    |
| 2024-09-30 | $51.84B   | 7.64%    |

**Analysis:**

*   **Revenue:** Shows fluctuations but generally remains in the $20-22 billion range.  The most recent quarter (2025-09-30) had the highest revenue.
*   **Profit Margin:**  Consistently high, hovering around 50-52%.  This indicates strong pricing power and efficient cost management.
*   **Equity:**  Growing steadily, reflecting retained earnings.
*   **ROE (Return on Equity):**  Fluctuates, but generally healthy (above 7%). The December quarter(2024-12-31) showed the best ROE.

**7. Comprehensive Analysis (Summary)**

*   **Underperformance:** PG has significantly underperformed the S&P 500 recently, with a substantial negative divergence.
*   **Mixed Signals:** Recent news and analyst opinions offer conflicting views, with some negative headlines balanced by an overall "Buy" consensus and a positive expected return.
*   **Financial Strength:** The company demonstrates solid financial health with strong profit margins, growing equity, and a healthy ROE.
*   **Technical Indicators:**  Technical indicators are mixed, with a neutral RSI, a slightly negative SMA trend, but a hybrid signal of "Buy".
*   **Key Takeaway:** PG appears to be a potentially undervalued stock with sound financials but recent performance struggles. The upcoming earnings report will likely be a significant catalyst. The high profit margins and strong brand recognition suggest the company has the potential to rebound. A positive development would be indicated by decreasing Maximum Drawdown.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.